Axogen AXGN

Axogen FY 2022: revenue $138.6M, up 9%; diluted EPS −$0.69

Form
10-K/A
Filed
Period
Importance
Routine
Document
10-K/A

Key figures from this report

These are the numbers Axogen reported for the year ended Dec 31, 2022, as tagged in the filing’s XBRL data, each against the year before. A plain-English reading of this report is not written yet.

  1. Revenue$138.6M+9% from $127.4M in FY 202110-K income statement, on EDGAR
  2. Net income−$28.9MAgainst −$27.0M in FY 202110-K income statement, on EDGAR
  3. Diluted EPS−$0.69Against −$0.65 in FY 202110-K income statement, on EDGAR
  4. Cash and cash equivalents$15.3M−53% from $32.8M in FY 2021Cash and equivalents only; the company page adds short-term investments.10-K balance sheet, on EDGAR
  5. Cash from operations−$16.1MAgainst −$13.4M in FY 202110-K cash flow statement, on EDGAR

Every year in the financial tables

Get an email when Axogen files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 3845 and related industry codes: the same peer list as the financial tables.

Data on this page was fetched . The filing on SEC.gov is the record.